Faribourz Payvandi
- Hematology top 1%
- Multiple Myeloma Research and Treatments 5
- Oncology top 5%
- Peptidase Inhibition and Analysis 2
- Cytokine Signaling Pathways and Interactions 2
- Immunology top 10%
- Immune Cell Function and Interaction 3
- Immune Response and Inflammation 3
- Cancer Research top 10%
- NF-κB Signaling Pathways 4
- Protease and Inhibitor Mechanisms 2
- Molecular Biology top 10%
- Protein Degradation and Inhibitors 2
- Co-authors
- George W. MullerDavid StirlingPeter SchäferRoger S. ChenPatricia Fitzgerald‐BocarslySheela AmruteAustin B. ThompsonStephen I. Rennard
- Cited by
- HematologyOncologyImmunology
- Journals
- Journal of Biological Chemistry (1 paper)The Journal of Immunology (1 paper)Cancer Research (2 papers)
- Partner nations
- United StatesSwitzerlandUkraine
In The Last Decade
Faribourz Payvandi
19 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 99
- Hematology 690
- Oncology 479
- Immunology 344
- Cancer Research 202
- Molecular Biology 815
Countries citing papers authored by Faribourz Payvandi
This map shows the geographic impact of Faribourz Payvandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faribourz Payvandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faribourz Payvandi more than expected).
Fields of papers citing papers by Faribourz Payvandi
This network shows the impact of papers produced by Faribourz Payvandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faribourz Payvandi. The network helps show where Faribourz Payvandi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Faribourz Payvandi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 15 | |
| 2 | 2008 | 183 | |
| 3 | The anticancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions | 2007 | 2 |
| 4 | 2006 | 77 | |
| 5 | 2005 | 40 | |
| 6 | A novel PDE4 inhibitory agent with endothelial cell specific activity. | 2004 | 1 |
| 7 | 2004 | 29 | |
| 8 | 2004 | 65 | |
| 9 | Selective cytokine inhibitory drugs with enhanced antiangiogenic activity control tumor growth through vascular inhibition. | 2003 | 14 |
| 10 | 2003 | 155 | |
| 11 | 2002 | 201 | |
| 12 | 2001 | 450 | |
| 13 | 1998 | 61 | |
| 14 | Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation. | 1998 | 71 |
| 15 | 1995 | 25 | |
| 16 | 1994 | 3 | |
| 17 | 1992 | 112 | |
| 18 | Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. | 1990 | 123 |
| 19 | 1989 | 1 |
About Faribourz Payvandi
Faribourz Payvandi is a scholar working on Cancer Research, Hematology and Immunology, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), NF-κB Signaling Pathways (4 papers), Immune Cell Function and Interaction (3 papers), Immune Response and Inflammation (3 papers), Protein Degradation and Inhibitors (2 papers), Peptidase Inhibition and Analysis (2 papers), Protease and Inhibitor Mechanisms (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Hematology (690 citations), Oncology (479 citations) and Immunology (344 citations). Faribourz Payvandi has collaborated with scholars based in United States, Switzerland and Ukraine. Frequent co-authors include George W. Muller, David Stirling, Peter Schäfer, Roger S. Chen, Patricia Fitzgerald‐Bocarsly, Sheela Amrute, Austin B. Thompson, Stephen I. Rennard, Linghua Zhang and Peter S. Amenta. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.